Psychosocial characteristics of New York City HIV-infected women before and after the advent of HAART

American Journal of Public Health

Volumn 94, Issue 7, 2004, Pages 1127-1132

  Siegel, Karolynn ^a   Karus, Daniel ^a   Dean, Laura ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADJUSTMENT; ADULT; ARTICLE; HEALTH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PSYCHOSOCIAL DISORDER; SOCIAL PSYCHOLOGY; UNITED STATES;

EID: 3042734581     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.94.7.1127     Document Type: Article

References (32)

1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
2. Detels R, Munoz A, McFarlame G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA. 1998;280:1497-1503.
3. Kobayashi JS. The evolution of adjustment issues in HIV/AIDS. Bull Menninger Clin. 1997;61:146-188.
4. Rabkin JG, Ferrando SJ. A "second life" agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. Arch Gen Psychiatry. 1997;54:1049-1053.
5. Kalichman SC, Ramachandran B. Mental health implications of new HIV treatments. In: Ostrow DG, Kalichman SC, eds. Psychosocial and Public Health Impacts of New HIV Therapies. New York, NY: Kluwer Academic/Plenum Publishers; 1995:137-150.
6. Siegel K, Schrimshaw EW. Reasons and justifications for considering pregnancy among women living with HIV/AIDS. Psychol Women Q. 2000;25:112-123.
7. Kelly JA, Otto-Salaj LL, Sikkema KJ, Pinkerton SD, Bloom FR. Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention. Health Psychol. 1998;17:310-319.
8. Moatti JP, Souteyrand Y. HIV/AIDS social and behavioral research: past advances and thoughts about the future. Soc Sci Med. 2000;50:1519-1532.
9. Rabkin JG, Ferrando SJ, Lin SH, Sewell M, McElhiney M. Psychological effects of HAART: a 2-year study. Psychosom Med. 2000;62:413-422.
10. BeLow-Beer S, Chan K, Yip B, et al. Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr. 2000;23: 295-301.
11. Judd FK, Cockram AM, Komiti A, Mijch AM, Hoy J, Bell R. Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study. Aust N Z J Psych. 2000; 34:1015-1021.
12. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA. 2001; 285:1465-1474.
13. Siegel K, Karus D, Raveis VH, Hagen D. Psychological adjustment of women with HIV: racial/ethnic comparisons. J Commun Psychol. 1998;26:439-455.
14. Karus D, Siegel K, Raveis VH. Psychosocial adjustment of women living with HIV/AIDS. AIDS Behav. 1999;3:277-287.
15. Comstock G, Helsing K. Symptoms of depression in two communities. Psychol Med 1976;6:551-563.
16. Radloff L. The CES-D scale. Appl Psychol Measure. 1977;1:385-401.
17. Radloff L, Locke B. The community mental health assessment survey and the CESD scale. In: Weissman M, Myers J, Ross C, eds. Community Surveys of Psychiatric Disorders. New Brunswick, NJ: Rutgers University Press; 1986:177-189.
18. Weissman M, Sholomskas D, Pottenger M, Prusoff B, Locke B. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 1977;106:203-214.
19. Hankin JR, Locke BZ. The persistence of depressive symptomatology among prepaid group practice enrollees: an exploratory study. Am J Public Health. 1982; 72:1000-1007
20. Radloff L, Teri L. Use of the Center for Epidemiological Studies-Depression Scale with older adults. Clin Gerontol. 1986;5:119-136.
21. Rosenberg M. Conceiving the Self. New York, NY: Basic Books; 1979.
22. Rosenberg M, Pearlin LI. Social class and self-esteem among children and adults. Am J Sociol. 1978; 84:53-77.
23. Veit C, Ware J. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol. 1983;51:730-742.
24. Derogatis L. The Psychological Adjustment to Illness Scale (PAIS). J Psychosom Res. 1986;30:77-91.
25. Derogatis L, Derogatis M. The Psychosocial Adjustment to Illness Scale (PAIS and PAISSR): Administration, Scoring and Procedures Manual-II. Baltimore, Md: Clinical Psychometric Research; 1990.
26. Herek G, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: prevalence and trends. Am J Public Health. 2002;92:371-376.
27. Brown GW. Single mothers, poverty and depression. Psychol Med. 1977;17:21-33.
28. Lynch JW, Kaplan GA, Shema SJ. Cumulative impact of sustained economic hardship on physical, cognitive, psychological and social functioning. N Engl J Med. 1997;26:1889-1895.
29. Ickovics JR, Druley JA, Morrill AC, Grigorenkio E, Rodin J. A grief observed: the experience of HIV-related illness and death among women in a clinic-based sample in New Haven, Connecticut. J Consult Clin Psychol. 1998;66:958-966.
30. Ciambrone D. Illness and other assaults on self: the relative impact of HIV/AIDS on women's lives. Sociol Health Illness. 2001;23:517-540.
31. Kalichman SC, Hunter TL, Kelly JA. Perceptions of AIDS risk susceptibility among minority and nonminority women at risk for HIV infection. J Consult Clin Psychol. 1992;60:725-732.
32. Maticka-Tyndale E, Adam BD, Cohen JJ. To work or not to work: combination therapies and HW. Qual Health Res. 2002;12:1353-1372.